Comparison of the efficacy and safety of ticagrelor and clopidogrel in patients with acute coronary syndrome after risk stratification.

Xiaoying LiMiaohan QiuKun NaYuzhuo LiSicong MaZizhao QiJing LiYi LiYa-Ling Han

Published in: Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions (2021)

Ticagrelor improves ischemic prognosis in intermediate- to high-risk patients but shows worse safety in low-risk patients compared to clopidogrel, supporting the effectiveness of risk score-guided decision making.

Keyphrases

acute coronary syndrome
end stage renal disease
percutaneous coronary intervention
ejection fraction
newly diagnosed
chronic kidney disease
antiplatelet therapy
decision making
randomized controlled trial
prognostic factors
systematic review
coronary artery disease
st segment elevation myocardial infarction